The first year of building something from scratch. A note from our founder on what it actually looks like behind the scenes.
Keep going.
#BuildInPublic#Fintech#AI
Two companies. Same ROE.
But one built it through genuine profitability and the other borrowed its way there.
The number alone won't tell you which is which.
India's ESG data exists. Thousands of BRSR filings, all technically there.
The problem is usability. No standard format, no way to compare across sectors.
Tickernaut fixes that.
Try it now → https://t.co/eIANQ9T3Lh
#esg#brsr#equityresearch
Research shouldn't feel like wading through noise. Scattered platforms, fragmented sources, hours spent finding one detail.
Tickernaut cuts through that. Ask your question, get the answer, traced to its source.
Try it now → https://t.co/eIANQ9SvVJ
#equityresearch#indianmarkets
Two things went live this week.
Tickernaut, an intent-driven equity research platform. And the blog where we publish the thinking behind it.
Try it → https://t.co/eIANQ9T3Lh
Read it → https://t.co/g4XkDDFbUI
#equityresearch#indianmarkets
When you're mid-research, you don't want more data. You want an answer.
That's intent-driven research.
Tickernaut is built for that.
Try it now → https://t.co/eIANQ9T3Lh
#equityresearch#indianmarkets
Indian equity research has an infrastructure problem.
The data exists. The filings are there. But the layer that understands what you're actually asking has never been built for this market.
That's the gap Tickernaut bridges.
Try it now → https://t.co/eIANQ9T3Lh
#equityresearch
5 problems every analyst in India knows too well.
Fragmented data. No source attribution. Hours lost in filings. Dashboard-driven tools. Unusable ESG data.
Tickernaut is built to solve all five.
Try it now → https://t.co/eIANQ9T3Lh
#equityresearch#indianmarkets
@IndianTechGuide I do NOT agree with Serum Institute (No rare cases) My mother is a victim,after vaccine, my mother started suffering from low platelets count(45K only).Too much mental and physical trauma. @PeterSweden7 Can someone help how should I file a similar legal case in India
@TimesNow@aakaaanksha@anchoramitaw Loop me in if you really want to put forward real facts. Serum cannot claim that "No cases of rare side effects found in India" , my family is a victim. We are dealing with low platelets count every day.
@TimesNow@aakaaanksha@anchoramitaw I do NOT agree with Serum Institute (No rare cases) My mother is a victim,after vaccine, my mother started suffering from low platelets count(45K only).Too much mental and physical trauma. @TimesNow@PeterSweden7 Can someone help how should I file a similar legal case in India